检索结果 - R. Katherine Alpaugh

Refine Results
  1. 1
    Circulating tumor cells: silent predictors of metastasis

    Circulating tumor cells: silent predictors of metastasis 由 Lanlan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El‐Deiry, R. Katherine Alpaugh

    出版 2017
    获取全文 获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  2. 2
    Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining

    Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining 由 Daniel L. Adams, R. Katherine Alpaugh, Susan Tsai, Cha-Mei Tang, Steingrimur Stefansson

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format

    Bispecific Minibodies Targeting HER2/neu and CD16 Exhibit Improved Tumor Lysis When Placed in a Divalent Tumor Antigen Binding Format 由 Lillian Shahied, Yong Tang, R. Katherine Alpaugh, Robert A. Somer, Dana Greenspon, Louis M. Weiner

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy

    Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy 由 Liat Binyamin, R. Katherine Alpaugh, Tracey L. Hughes, Charles T. Lutz, Kerry S. Campbell, Louis M. Weiner

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Regulation of Antibody-Dependent Cellular Cytotoxicity by IgG Intrinsic and Apparent Affinity for Target Antigen

    Regulation of Antibody-Dependent Cellular Cytotoxicity by IgG Intrinsic and Apparent Affinity for Target Antigen 由 Yong Tang, Jianlong Lou, R. Katherine Alpaugh, Matthew K. Robinson, James D. Marks, Louis M. Weiner

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients

    Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients 由 Catherine April Bingham, Sandra V. Fernandez, Patricia Fittipaldi, Paul W. Dempsey, Karen Ruth, Massimo Cristofanilli, R. Katherine Alpaugh

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch<sup>®</sup> CTC test

    Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch<sup>®</sup> CTC test 由 Daniel L. Adams, Steingrimur Stefansson, Christian Haudenschild, Stuart S. Martin, Monica S. Charpentier, Saranya Chumsri, Massimo Cristofanilli, Cha‐Mei Tang, R. Katherine Alpaugh

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions

    Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions 由 Daniel L. Adams, Diane K. Adams, R. Katherine Alpaugh, Massimo Cristofanilli, Stuart S. Martin, Saranya Chumsri, Cha-Mei Tang, Jeffrey R. Marks

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas

    Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas 由 Daniel L. Adams, Diane K. Adams, Steingrimur Stefansson, Christian Haudenschild, Stuart S. Martin, Monica S. Charpentier, Saranya Chumsri, Massimo Cristofanilli, Cha-Mei Tang, R. Katherine Alpaugh

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

    NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors 由 Alexander W. MacFarlane, Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion Cole, Samuel Litwin, Michael Millenson, Tahseen Al‐Saleem, Adam D. Cohen, Kerry S. Campbell

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony- stimulating factor

    CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony- stimulating factor 由 MN Saleh, SJ Goldman, AF LoBuglio, Beall Ac, Hernan Sabio, MC McCord, Lori M. Minasian, R. Katherine Alpaugh, L M Weiner, David H. Munn

    出版 1995
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton... 由 Kian Behbakht, Michael W. Sill, Kathleen M. Darcy, Stephen C. Rubin, Robert S. Mannel, Steven Waggoner, Russell J. Schilder, Kathy Q. Cai, Andrew K. Godwin, R. Katherine Alpaugh

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Circulating giant macrophages as a potential biomarker of solid tumors

    Circulating giant macrophages as a potential biomarker of solid tumors 由 Daniel L. Adams, Stuart S. Martin, R. Katherine Alpaugh, Monica S. Charpentier, Susan Tsai, Raymond C. Bergan, Irene Ogden, William J. Catàlona, Saranya Chumsri, Cha-Mei Tang, Massimo Cristofanilli

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Individualized Patient Dosing in Phase I Clinical Trials: The Role of Escalation With Overdose Control in PNU-214936

    Individualized Patient Dosing in Phase I Clinical Trials: The Role of Escalation With Overdose Control in PNU-214936 由 Jonathan D. Cheng, James S. Babb, Corey J. Langer, Steinar Aamdal, Francisco Robert, Lars Engelhardt, Olov Fernberg, Joan H. Schiller, G. Forsberg, R. Katherine Alpaugh, Louis M. Weiner, André Rogatko

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Response of an <i>ERBB2</i>-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy

    Response of an <i>ERBB2</i>-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy 由 Siraj M. Ali, R. Katherine Alpaugh, Sean R. Downing, Philip J. Stephens, Jian Yu, Hong Wu, Jamie Buell, Vincent A. Miller, Doron Lipson, Gary A. Palmer, Jeffrey S. Ross, Massimo Cristofanilli

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

    Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma 由 Efrat Dotan, R. Katherine Alpaugh, Karen Ruth, Benjamin P. Negin, Crystal S. Denlinger, Michael J. Hall, Igor Astsaturov, C McAleer, Patricia Fittipaldi, Catherine Thrash-Bingham, Neal J. Meropol, Steven J. Cohen

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

    Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. 由 Aarti Bhatia, Ranee Mehra, Jessica R. Bauman, Saad A. Khan, Wei Wei, Veronique Neumeister, Teresa Sandoval-Schaefer, R. Katherine Alpaugh, Miriam N. Lango, David L. Rimm, John A. Ridge, Barbara Burtness

    出版 2025
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  18. 18
    Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

    Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study 由 Russell J. Schilder, William E. Brady, Heather A. Lankes, James V. Fiorica, Mark S. Shahin, Xun Zhou, Robert S. Mannel, Harsh B. Pathak, Wei Hu, R. Katherine Alpaugh, Anil K. Sood, Andrew K. Godwin

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Biodistribution and Radiation Dosimetry of the Integrin Marker <sup>18</sup>F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans

    Biodistribution and Radiation Dosimetry of the Integrin Marker <sup>18</sup>F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans 由 Mohan Doss, Hartmuth C. Kolb, Jinjun Zhang, Marie-José Bélanger, James B. Stubbs, Michael G. Stabin, Eric D. Hostetler, R. Katherine Alpaugh, Margaret von Mehren, Joseph C. Walsh, Michael Haka, Vani P. Mocharla, Jian Q. Yu

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

    Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials 由 Namrata Vijayvergia, Arvind Dasari, Mengying Deng, Samuel Litwin, Taymeyah Al‐Toubah, R. Katherine Alpaugh, Efrat Dotan, Michael J. Hall, Nicole Ross, Melissa M. Runyen, Crystal S. Denlinger, Daniel M. Halperin, Steven J. Cohen, Paul F. Engstrom, Jonathan Strosberg

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: